Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Clopamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | GLA | P06280 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 11/20 | 0.45 |
| ▸ | CA2 | P00918 | 11/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indapamide SCHEMBL7622426 | 0.83 | CA2 (0.71) | LMNAHSD17B10KDM4EGLAMAPT | |
| Clopamide SCHEMBL124598 | 0.82 | KDM4E (1.00) | LMNAHSD17B10KDM4EGLAMAPT | |
| Clopamide SCHEMBL1650071 | 0.82 | KDM4E (1.00) | LMNAHSD17B10KDM4EGLAMAPT | |
| Cyclopenthiazide SCHEMBL28279853 | 0.78 | LMNA (0.66) | LMNAHSD17B10KDM4EGLAMAPT | |
| Quinethazone SCHEMBL29688344 | 0.77 | LMNA (1.00) | LMNAHSD17B10KDM4EHTTUSP2 | |
| Quinethazone SCHEMBL380450 | 0.77 | LMNA (1.00) | LMNAHSD17B10KDM4EHTTUSP2 | |
| Quinethazone SCHEMBL301310 | 0.77 | LMNA (1.00) | LMNAHSD17B10KDM4EHTTUSP2 | |
| SCHEMBL27462399 | 0.76 | LMNA (0.83) | LMNAHSD17B10KDM4EGLAMAPT | |
| Indapamide SCHEMBL7620494 | 0.76 | ALDH1A1 (0.59) | LMNAHSD17B10KDM4EGLAMAPT | |
| Clopamide SCHEMBL28086350 | 0.73 | MAPT (0.66) | LMNAHSD17B10KDM4EGLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103717597-B | Heterocyclic compounds as kinase inhibitors | 原真股份有限公司 | 2017-07-04 | — | — | CN | disclosed |
| CN-103492389-B | Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases | 原真股份有限公司 | 2016-09-14 | — | — | CN | disclosed |